Hippocrates Briefs Team – Page 113

Empagliflozin for HF-pEF and Its Effects on Patients...

3 min read

Empagliflozin has been established as one of the possible key treatments for patients with heart...

2 min read

Just close to a month after the CMS released their 2023 Medicare Physician Fee Schedule proposed...

3 min read

This study was carried out to check the efficacy of empagliflozin in heart failure patients. For...

1 min read

Read further: Trial Study to Show Empagliflozin Outcomes In Patients of Chronic Heart Failure and...

2 min read

Eligible asymptomatic individuals between the age range 40-50 years from the progression of early...

3 min read

The DYNAMIC trial study was a randomized, multicenter, placebo-controlled, double-blind IIB trial...

3 min read

During dual antiplatelet therapy, Cangrelor or eptifibatide, etc., short-acting parental...

3 min read

While it is known that empagliflozin plays a vital role in reducing cardiovascular death (CVD) or...

4 min read

Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are drugs...

3 min read

The American Heart Association (AHA) worked on cardiovascular health, and in 2010 they defined a...